Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
92.60 +1.49  +1.64% NASDAQ Mar 27, 5:00PM BATS Real time Currency in USD

Pacira Pharmaceuticals Total Liabilities (Quarterly):

154.93M for Dec. 31, 2014

View 4,000+ financial data types

View Full Chart

Pacira Pharmaceuticals Total Liabilities (Quarterly) Chart

Export Data
Save Image

Pacira Pharmaceuticals Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2009. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2014 154.93M
Sept. 30, 2014 150.32M
June 30, 2014 144.11M
March 31, 2014 127.98M
Dec. 31, 2013 128.57M
Sept. 30, 2013 123.28M
June 30, 2013 119.29M
March 31, 2013 115.45M
Dec. 31, 2012 46.20M
Sept. 30, 2012 52.38M
June 30, 2012 48.35M
March 31, 2012 57.02M
Dec. 31, 2011 65.22M
Sept. 30, 2011 63.73M
June 30, 2011 64.16M
March 31, 2011 66.72M
Dec. 31, 2010 114.94M
Sept. 30, 2010 95.79M
June 30, 2010 84.47M
Dec. 31, 2009 66.90M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Get data for

PCRX Total Liabilities (Quarterly) Benchmarks

Alimera Sciences 59.89M
Assembly Biosciences 1.470M
Intercept Pharmaceuticals 23.26M

PCRX Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 46.20M Dec 2012
Maximum 154.93M Dec 2014
Average 95.94M

PCRX Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("PCRX", "liabilities")
  • Last 5 data points: =YCS("PCRX", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.